Reference number : 172-2020-2021-Q2-953967, amendment number : , agreement type : C, recipient legal name : Orion Biotechnology Canada Ltd., recipient country : CA, recipient province : ON, recipient city : Ottawa|Ottawa, recipient postal code : K1S 1N4, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Development of a Treatment for COVID-19, agreement title french : Mise au point d'un traitement contre la COVID-19, agreement number : 953967, agreement value : 376168.0, agreement start date : 2020-06-01, agreement end date : 2021-02-28, description english : Orion Biotechnology is developing a novel biologic for the treatment of SARS-CoV-2., description french : Orion Biotechnology met au point un nouveau produit biologique pour le traitement du SRAS-CoV-2., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada